Hall Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.98M Sell
4,889
-903
-16% -$366K 0.84% 41
2025
Q1
$2.88M Buy
5,792
+294
+5% +$146K 1.34% 25
2024
Q4
$2.86M Buy
+5,498
New +$2.86M 1.33% 23
2024
Q2
$3.02M Buy
5,454
+233
+4% +$129K 1.44% 22
2024
Q1
$3.03M Buy
5,221
+31
+0.6% +$18K 1.5% 23
2023
Q4
$2.75M Buy
5,190
+198
+4% +$105K 1.62% 23
2023
Q3
$2.53M Buy
4,992
+466
+10% +$236K 1.62% 23
2023
Q2
$2.36M Buy
4,526
+51
+1% +$26.6K 1.33% 28
2023
Q1
$2.58M Sell
4,475
-121
-3% -$69.7K 1.53% 25
2022
Q4
$2.53M Sell
4,596
-18
-0.4% -$9.91K 1.52% 27
2022
Q3
$2.34M Sell
4,614
-201
-4% -$102K 1.56% 27
2022
Q2
$2.62M Buy
4,815
+82
+2% +$44.6K 1.72% 25
2022
Q1
$2.8M Buy
4,733
+25
+0.5% +$14.8K 1.64% 22
2021
Q4
$3.14M Buy
4,708
+229
+5% +$153K 1.78% 21
2021
Q3
$2.56M Buy
4,479
+30
+0.7% +$17.1K 1.63% 22
2021
Q2
$2.24M Buy
+4,449
New +$2.24M 1.45% 27
2020
Q4
$2.69M Buy
5,769
+191
+3% +$89K 1.94% 19
2020
Q3
$2.45M Buy
5,578
+332
+6% +$146K 1.94% 19
2020
Q2
$1.9M Buy
5,246
+142
+3% +$51.5K 1.6% 23
2020
Q1
$1.45M Buy
5,104
+264
+5% +$74.8K 1.48% 25
2019
Q4
$1.57M Buy
4,840
+170
+4% +$55.2K 1.28% 29
2019
Q3
$1.36M Buy
4,670
+195
+4% +$56.8K 1.19% 33
2019
Q2
$1.31M Buy
4,475
+585
+15% +$172K 1.12% 34
2019
Q1
$1.07M Buy
3,890
+320
+9% +$87.6K 0.93% 41
2018
Q4
$799K Sell
3,570
-210
-6% -$47K 0.79% 44
2018
Q3
$923K Buy
3,780
+220
+6% +$53.7K 0.8% 44
2018
Q2
$737K Hold
3,560
0.69% 48
2018
Q1
$735K Sell
3,560
-100
-3% -$20.6K 0.71% 46
2017
Q4
$695K Hold
3,660
0.61% 49
2017
Q3
$692K Sell
3,660
-173
-5% -$32.7K 0.64% 49
2017
Q2
$669K Sell
3,833
-25
-0.6% -$4.36K 0.63% 49
2017
Q1
$593K Sell
3,858
-200
-5% -$30.7K 0.56% 53
2016
Q4
$572K Buy
+4,058
New +$572K 0.56% 54
2015
Q3
$480K Buy
3,933
+112
+3% +$13.7K 0.57% 51
2015
Q2
$495K Sell
3,821
-100
-3% -$13K 0.56% 52
2015
Q1
$526K Sell
3,921
-50
-1% -$6.71K 0.55% 53
2014
Q4
$497K Buy
+3,971
New +$497K 0.51% 56